{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:32:00Z","timestamp":1777879920906,"version":"3.51.4"},"reference-count":92,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Infection"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections affect millions of persons around the globe and cause profound morbidity and mortality. A major intersection exists between these two epidemics, with HCV infection being more common in persons with HIV than in the general population, largely due to shared routes of transmission. HCV co-infection increases risk for liver- and non-liver-related morbidity and mortality, making HCV treatment a priority in HIV co-infected persons, but the treatment of HCV in co-infected patients has been daunting for multiple reasons. Until recently, HCV treatment has frequently been deferred due to the low rates of cure, significant adverse effects, burdensome duration of therapy and drug\u2013drug interactions with HIV antiretroviral medications. Untreated HCV has resulted in significant health consequences for the millions of those infected and has led to multiple downstream impacts on our healthcare systems around the world. The development of a remarkable number of new HCV direct-acting agents (DAAs) that are significantly more efficacious and tolerable than the previous interferon-based regimens has transformed this important field of medicine, with the potential to dramatically reduce the burden of infection and improve health outcomes in this population. This review will summarize the epidemiology and clinical impact of HIV\/HCV co-infection and current approaches to the treatment of HCV in HIV\/HCV co-infected patients.<\/jats:p>","DOI":"10.1177\/2049936116681279","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T03:44:24Z","timestamp":1481341464000},"page":"18-36","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment optimization for HIV\/HCV co-infected patients"],"prefix":"10.1177","volume":"4","author":[{"given":"Jake A.","family":"Scott","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara W.","family":"Chew","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"bibr1-2049936116681279","unstructured":"AASLD-IDSA. (n.d.) Recommendations for Testing, Managing, and Treating Hepatitis C. Available at: http:\/\/www.hcvguidelines.org (accessed 13 October 2016)."},{"key":"bibr2-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"bibr3-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"bibr4-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.004"},{"key":"bibr5-2049936116681279","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0406"},{"key":"bibr6-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23020"},{"key":"bibr7-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis500"},{"key":"bibr8-2049936116681279","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2674"},{"key":"bibr9-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ838"},{"key":"bibr10-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv168"},{"key":"bibr11-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.23.2839"},{"key":"bibr12-2049936116681279","unstructured":"Centers for Disease Control and Prevention, C. (2014) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas, 2012. Available at: http:\/\/www.cdc.gov\/hiv\/pdf\/surveillance_report_vol_19_no_3.pdf"},{"key":"bibr13-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/644771"},{"key":"bibr14-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032653"},{"key":"bibr15-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512614"},{"key":"bibr16-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/587843"},{"key":"bibr17-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25556"},{"key":"bibr18-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu675"},{"key":"bibr19-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000363"},{"key":"bibr20-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"bibr21-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"bibr22-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"bibr23-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cku139"},{"key":"bibr24-2049936116681279","volume-title":"Presented at the American Association for the Study of Liver Diseases","author":"Fierer D.","year":"2015"},{"key":"bibr25-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/590430"},{"key":"bibr26-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/427452"},{"key":"bibr27-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"bibr28-2049936116681279","unstructured":"Gilead Sciences. (2015) HARVONI (R) (ledipasvir and sofosbuvir) (package insert). Foster City, CA: Gilead Sciences, Inc. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/205834s006lbl.pdf (accessed 14 October 2016)."},{"key":"bibr29-2049936116681279","unstructured":"Gilead Sciences. (2016) EPCLUSA (R) (sofosbuvir and velpatasvir) (package insert). Foster City, CA: Gilead Sciences, Inc. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208341s000lbl.pdf (accessed 14 October 2016)."},{"key":"bibr30-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/321909"},{"key":"bibr31-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000887"},{"key":"bibr32-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000834"},{"key":"bibr33-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.051"},{"key":"bibr34-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis968"},{"key":"bibr35-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw567"},{"key":"bibr36-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25800"},{"key":"bibr37-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"bibr38-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"bibr39-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011232"},{"key":"bibr40-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.01.034"},{"key":"bibr41-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0261-7"},{"key":"bibr42-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.106"},{"key":"bibr43-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25653"},{"key":"bibr44-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807252"},{"key":"bibr45-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"bibr46-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000494"},{"key":"bibr47-2049936116681279","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(14)61795-5","volume":"385","author":"Lawitz E.","year":"2015","journal-title":"Lancet"},{"key":"bibr48-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"bibr49-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61036-9"},{"key":"bibr50-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7844"},{"key":"bibr51-2049936116681279","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M13-1829","volume":"160","author":"Lo Re V.","year":"2014","journal-title":"Ann Intern Med"},{"key":"bibr52-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit373"},{"key":"bibr53-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.19289"},{"key":"bibr54-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"bibr55-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62483-1"},{"key":"bibr56-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/321819"},{"key":"bibr57-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501315"},{"key":"bibr58-2049936116681279","volume-title":"Presented at the American Association for the Study of Liver Diseases","author":"Naggie S.","year":"2015"},{"key":"bibr59-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.109309"},{"key":"bibr60-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1373"},{"key":"bibr61-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S6-S5"},{"key":"bibr62-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"bibr63-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30154-9"},{"key":"bibr64-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411190-00009"},{"key":"bibr65-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit302"},{"key":"bibr66-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00114-9"},{"key":"bibr67-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.005"},{"key":"bibr68-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081355"},{"key":"bibr69-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60604-8"},{"key":"bibr70-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.10.021"},{"key":"bibr71-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27553"},{"key":"bibr72-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/429489"},{"key":"bibr73-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1328"},{"key":"bibr74-2049936116681279","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(14)61793-1","volume":"385","author":"Sulkowski M.","year":"2015","journal-title":"Lancet"},{"key":"bibr75-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1086\/313842"},{"key":"bibr76-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7734"},{"key":"bibr77-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70149-X"},{"key":"bibr78-2049936116681279","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7326\/0003-4819-159-2-201307160-00654","volume":"159","author":"Sulkowski M.","year":"2013","journal-title":"Ann Intern Med"},{"key":"bibr79-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.450"},{"key":"bibr80-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.690"},{"key":"bibr81-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040842"},{"key":"bibr82-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ677"},{"key":"bibr83-2049936116681279","unstructured":"U.S. Food and Drug Administration (FDA). (2015a) FDA Drug Safety Communication: FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM468755.pdf (released 22 October 2015)."},{"key":"bibr84-2049936116681279","unstructured":"U.S. Food and Drug Administration (FDA). (2015b) U.S. Food and Drug Administration Drug Safety Communication. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm439484.htm (accessed 15 October 2016)."},{"key":"bibr85-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000275"},{"key":"bibr86-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir854"},{"key":"bibr87-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.15.1632"},{"key":"bibr88-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103345"},{"key":"bibr89-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28334"},{"key":"bibr90-2049936116681279","volume-title":"Presented at the 51st Annual Meeting of the European Association for the Study of the Liver (EASL)","author":"Wyles D.","year":"2016"},{"key":"bibr91-2049936116681279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503153"},{"key":"bibr92-2049936116681279","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0785"}],"container-title":["Therapeutic Advances in Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2049936116681279","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2049936116681279","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2049936116681279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:57:05Z","timestamp":1777593425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2049936116681279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1177\/2049936116681279"],"URL":"https:\/\/doi.org\/10.1177\/2049936116681279","relation":{},"ISSN":["2049-9361","2049-937X"],"issn-type":[{"value":"2049-9361","type":"print"},{"value":"2049-937X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}